XML 37 R26.htm IDEA: XBRL DOCUMENT
v3.24.3

Stockholders’ Equity (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2024
Equity [Abstract] |
Summary of RSU Activity | For the nine months ended September 30, 2024, a summary of RSU activity is as follows: Summary of RSU Activity
|  | Shares |  |  | Weighted Average Grant Date Fair Value |
Outstanding as of December 31, 2023 |  |  | 152,703 |  |  | $ | 18.03 |
Granted |  |  | 399,073 |  |  |  | 0.33 |
Cancelled |  |  | (2,140 | ) |  |  | 10.09 |
Vested and released |  |  | (34,361 | ) |  |  | 15.06 |
Outstanding as of September 30, 2024 |  |  | 515,275 |  |  |  | 4.66 |
Vested as of September 30, 2024 |  |  | 149,046 |  |  |  | 14.87 |
Unvested as of September 30, 2024 |  |  | 366,229 |  |  | $ | 0.51 |
For the nine months ended September 30, 2023, a summary of RSU activity is as follows:
|  | Shares |  |  | Weighted Average Grant Date Fair Value |
Outstanding as of December 31, 2022 |  |  | 51,484 |  |  | $ | 46.20 |
Granted |  |  | 100,036 |  |  |  | 7.11 |
Cancelled |  |  | (7,677 | ) |  |  | 31.46 |
Vested and released |  |  | (19,375 | ) |  |  | 7.68 |
Outstanding as of September 30, 2023 |  |  | 124,468 |  |  |  | 21.70 |
Vested as of September 30, 2023 |  |  | 103,511 |  |  |  | 20.28 |
Unvested as of September 30, 2023 |  |  | 20,957 |  |  | $ | 28.70 |
Schedule of Options Activity | For the nine months ended September 30, 2024, a summary of the options activity is as follows: Schedule of Options Activity
|  | Shares |  |  | Weighted Average Exercise Price |  |  | Weighted Average Fair Value |  |  | Weighted Average Remaining Contractual Term (Years) |  |  | Aggregate Intrinsic Value |
Outstanding as of December 31, 2023 |  |  | 125,264 |  |  | $ | 40.61 |  |  | $ | 22.04 |  |  |  | 23.80 |  |  | $ | 45,880 |
Granted |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Exercised |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Expired/Forfeited |  |  | (122,514 | ) |  |  | 39.11 |  |  |  | 21.24 |  |  |  | — |  |  |  | — |
Outstanding as of September 30, 2024 |  |  | 2,750 |  |  | $ | 105.96 |  |  | $ | 57.01 |  |  |  | 1.78 |  |  | $ | — |
Exercisable as of September 30, 2024 |  |  | 2,750 |  |  | $ | 105.96 |  |  | $ | 57.01 |  |  |  | 1.78 |  |  | $ | — |
For the nine months ended September 30, 2023, a summary of the options activity is as follows:
|  | Shares |  |  | Weighted Average Exercise Price |  |  | Weighted Average Fair Value |  |  | Weighted Average Remaining Contractual Term (Years) |  |  | Aggregate Intrinsic Value |
Outstanding as of December 31, 2022 |  |  | 128,059 |  |  | $ | 43.68 |  |  | $ | 23.76 |  |  |  | 3.33 |  |  | $ | 9,750 |
Granted |  |  | 16,250 |  |  |  | 6.45 |  |  |  | 2.96 |  |  |  | 3.02 |  |  |  | — |
Exercised |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Expired/Forfeited |  |  | (7,230 | ) |  |  | 69.20 |  |  |  | 38.12 |  |  |  | — |  |  |  | — |
Outstanding as of September 30, 2023 |  |  | 137,079 |  |  | $ | 37.92 |  |  | $ | 20.54 |  |  |  | 2.84 |  |  | $ | 6,194 |
Exercisable as of September 30, 2023 |  |  | 114,746 |  |  | $ | 43.56 |  |  | $ | 23.70 |  |  |  | 2.53 |  |  | $ | 6,194 |
Schedule of Significant Weighted Average Assumptions | For the nine months ended September 30, 2024 and 2023, the significant assumptions relating to the valuation of the Company’s stock options granted were as follows: Schedule of Significant Weighted Average Assumptions
|  | 2024 |  |  | 2023 |
|  | September 30, |
|  | 2024 |  |  | 2023 |
Stock price |  | $ | — |  |  | $ | 6.40 |
Dividend yield |  |  | — | % |  |  | — | %
Expected life (years) |  |  | — |  |  |  | 3.02 |
Expected volatility |  |  | — | % |  |  | 63.64 | %
Risk-free interest rate |  |  | — | % |  |  | 4.22 | %

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Subparagraph (f)(2) -Name Accounting Standards Codification -Paragraph 2 -Section 50 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration